ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

9560	Companies
188848	Keywords
120587	Articles
100788	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/08/2024 at 08:31, 1 year 7 months ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024. Des nouvelles données seront partagées concernant le candidat médicament obefazimod

Abivax Obefazimod Rectocolite Hémorragique Digestive Disease Week Cancer Du Côlon
PRESS RELEASE

published on 05/08/2024 at 08:31, 1 year 7 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod

Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
PRESS RELEASE

published on 05/08/2024 at 08:30, 1 year 7 months ago

Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024
Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024

Abivax Obefazimod Rectocolite Hémorragique Cancer Du Côlon Digestive Disease Week 2024
PRESS RELEASE

published on 05/08/2024 at 08:30, 1 year 7 months ago

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action

Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF

published on 05/07/2024 at 22:05, 1 year 7 months ago

Abivax Announces Availability of Documents for Upcoming General Meeting

Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF

published on 05/07/2024 at 22:05, 1 year 7 months ago

Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale

Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE

published on 05/07/2024 at 22:01, 1 year 7 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires

Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 7 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 7 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 7 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires

Accesswire

Published on 12/20/2025 at 00:30, 16 hours 33 minutes ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 19 hours 3 minutes ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 22 hours 33 minutes ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 1 day 2 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 day 3 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/20/2025 at 16:45, 17 minutes ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 6 hours 57 minutes ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 19 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 19 hours 22 minutes ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 20 hours 27 minutes ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy

Les Echos

Published on 12/19/2025 at 21:57, 19 hours 6 minutes ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 8 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 8 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 10 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 10 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE